LAT1-IN-2 hydrochloride
LAT1-IN-2 hydrochloride is an orally active anticancer agent, as well as a LAT1 substrate and tubulin-binding agent. LAT1-IN-2 hydrochloride relies on LAT1 for cellular uptake, disrupts microtubule formation by binding to the colchicine site of tubulin, and induces actin depolymerization to transform cells into a spherical shape. LAT1-IN-2 hydrochloride effectively inhibits tumor growth in xenograft mice. Compared with Etoposide (HY-13629), LAT1-IN-2 hydrochloride shows higher distribution in tumor tissues, lower distribution in major organs, and better tolerability. LAT1-IN-2 hydrochloride has been applied in studies related to esophageal cancer.
For research use only. We do not sell to patients.
- Formula: C28H32ClNO11
- Molecular Weight:594.01
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
LAT1-IN-2 hydrochloride (B11) (0.01-50 μM; 72 h) potently inhibits the proliferation of A549, Eca109, MM.1S, and NUGC-4 cells, with the highest activity against Eca109 cells (IC50 = 0.048 μM)[1].
LAT1-IN-2 hydrochloride (0.1-10 μM; 24 h) disrupts the actin cytoskeleton of Eca109 cells in a concentration-dependent manner, inducing actin depolymerization and spherical cell morphology[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:human lung carcinoma A549 cells, human esophageal carcinoma Eca109 cells, human multiple myeloma MM.1S cells, human gastric carcinoma NUGC-4 cells
-
Concentration:0.01 μM, 0.05 μM, 0.1 μM, 0.5 μM, 1 μM, 10 μM, 50 μM
-
Incubation Time:72 h
-
Result:Exhibited potent antiproliferative activity across all four cell lines, with IC50 values of 0.233 μM (A549), 0.048 μM (Eca109), 0.899 μM (MM.1S), and 0.252 μM (NUGC-4).
Showed significantly different IC50 values from the positive control etoposide for all cell lines except MM.1S.
-
Cell Line:human esophageal carcinoma Eca109 cells
-
Concentration:0.1 μM, 10 μM
-
Incubation Time:24 h
-
Result:Caused significant disruption of the actin cytoskeleton at 0.1 μM, with actin bundles largely absent and reduced F-actin distribution, resulting in spherical cell morphology.
Induced more intense cytoskeletal damage, membrane deformation, and nuclear deformation at 10 μM.
LAT1-IN-2 hydrochloride (20-40 mg/kg; p.o.; daily; 14 days) dose-dependently inhibits esophageal tumor growth in BALB/c nude mice[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c nude mice with Esophageal cancer (female, 5 weeks old)[1]
-
Dosage:20 mg/kg; 40 mg/kg
-
Administration:p.o.; daily; 14 days
-
Result:Achieved a tumor growth inhibition (TGI) of 41.50% based on tumor weight at 20 mg/kg.
Achieved a TGI of 64.58% based on tumor weight at 40 mg/kg.
Kept all animals in good health with no clinical behavioral or pathological differences observed during treatment.
Chemical Information
-
Molecular Weight 594.01
-
Formula C28H32ClNO11
-
SMILES
O=C(O)[C@@H](N)CCCC(O[C@@H]1[C@]2([H])[C@@](C(OC2)=O)([H])[C@H](C3=CC(OC)=C(OC)C(OC)=C3)C4=C1C=C5OCOC5=C4)=O.Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
LAT1-IN-2 hydrochloride Related Classifications
HY-183147A Related Classifications
Powered by Bioz